4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Ocular Therapeutix, Inc. (OCUL) operates in the Biotechnology industry and is headquartered in Bedford, United States with about 325 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, OCUL reported $52M in revenue and ($266M) in net income.
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.
Interactive charts & full statements → Open the OCUL valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $52M | $64M | $58M | $52M | — |
| Gross Profit | $45M | $58M | $53M | $47M | — |
| Operating Income (EBIT) | ($270M) | ($172M) | ($82M) | ($79M) | — |
| Net Income | ($266M) | ($194M) | ($81M) | ($71M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $11M | $13M | $14M | $14M | $11M | — |
| Gross Profit | $10M | $12M | $13M | $12M | $9M | — |
| Operating Income (EBIT) | ($93M) | ($70M) | ($69M) | ($68M) | ($64M) | — |
| Net Income | ($89M) | ($65M) | ($69M) | ($68M) | ($64M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $808M | $458M | $252M | $149M | — |
| Total Liabilities | $154M | $143M | $161M | $114M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OCUL viewer.
About TickerBase · Data methodology & sources